Clinical Trials on Hormone Receptor Positive in Switzerland

Total 597 results

University Hospital Inselspital, Berne
University of Zurich; University Hospital Muenster

Completed

Genetic Polymorphism of the Androgen Receptor-Gene and Sexual Function in Middle Aged Women (CAG-Libido)

Polymorphism, Genetic | Libido | Receptors, Androgen | Androgen Effect

Switzerland
Prof. Wolfgang Janni
Eli Lilly and Company

Recruiting

Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management (MINERVA)

Hormone Receptor-positive Metastatic Breast Cancer | HER2-negative Metastatic Breast Cancer

Germany, Switzerland
ETOP IBCSG Partners Foundation
Pfizer; Hoffmann-La Roche

Completed

To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH) (TOUCH)

Breast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive Tumor

France, Switzerland, Belgium, Italy
North Eastern German Society of Gynaecological...
Center for Clinical Trials Philipps University Marburg

Active, not recruiting

Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer (RESCUE)

Estrogen Receptor Positive Tumor | Primary Invasive Breast Cancer | Human Epidermal Growth Factor Receptor 2 Negative Tumor

Germany, Switzerland
ETOP IBCSG Partners Foundation
National Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaborators

Active, not recruiting

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer (SOFT)

Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive Tumor

United States, Canada, Switzerland
University Children's Hospital Basel

Recruiting

Electrical Impedance Tomography for Identification of Optimal Positive End-expiratory Pressure in Newborn Infants

Positive End-expiratory Pressure (PEEP)

Switzerland
Hôpital Fribourgeois

Recruiting

Effect of Positive Therapeutic Communication on Pain (POPAIN)

Effect of Positive Therapeutic Communication on Pain

Switzerland
University of Zurich

Unknown

Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding Study

Gram-Positive Bacterial Infections

Switzerland
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive Adults

Tuberculosis (TB)

Switzerland
University Hospital, Basel, Switzerland
Fachhochschule Nordwestschweiz

Withdrawn

miRNA in Sweat, a Novel Digital Biomarker for Detection of Active Tuberculosis (TB)

Active Tuberculosis

Switzerland
GlaxoSmithKline

Completed

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.

Tuberculosis

Switzerland
University Children's Hospital Basel

Terminated

Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Streptococcal Dermatitis

Streptococcal Infections

Switzerland
University Hospital, Basel, Switzerland

Completed

Diagnosing of Acute Tuberculosis (SwEaTB)

Tuberculosis

Switzerland
University Hospital, Geneva

Completed

An Ecological Analysis of Nontuberculous Mycobacteria in the Geneva Area (2015-2020)

Ecology of Nontubercuous Mycobacteria | Geneva Area

Switzerland
Aeras
Sanofi Pasteur, a Sanofi Company

Completed

A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults (C-013-404)

Tuberculosis

Switzerland
University of Zurich

Recruiting

Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy

Tuberculosis Infection

Switzerland
University Hospital, Basel, Switzerland
propatient foundation Basel

Completed

Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus (TARGET II)

Staphylococcus Aureus Infection

Switzerland
University Hospital, Geneva
Ligue Pulmonaire Genevoise

Completed

Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area

Tuberculosis | Latent Tuberculosis Infection

Switzerland
University Hospital, Geneva
Ligue Pulmonaire Genevoise

Completed

Results of an Interferon-Gamma Release Assay After Treatment for Tuberculosis

Tuberculosis

Switzerland
University Hospital, Basel, Switzerland
Swiss Tropical & Public Health Institute; Ifakara Health Institute

Completed

Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan Africa (RenalOne)

HIV Infections | Hypertension | Diabetes Mellitus | Chronic Kidney Diseases | Tuberculosis | Schistosomiasis

Switzerland
François Spertini
University of Oxford

Completed

ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039) (TB039)

Tuberculosis | Mycobacterium Tuberculosis, Protection Against

Switzerland
University Hospital, Basel, Switzerland

Completed

Prosthetic Valve and Graft Endocarditis With Mycobacterium Chimaera

Mycobacterium Chimaera Infections

Switzerland
University Hospital, Geneva
Swiss National Science Foundation; University of Applied Sciences of Western...

Completed

Maternal Positioning and Occipitoposterior Fetal Position

Dystocia | Maternal Distress in Labor | Persistent Occipitoposterior or Occipitoanterior Position | Fetal Position and Presentation Abnormalities

Switzerland
Benoit Guery

Recruiting

Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence (FENDER)

Clostridioides Difficile Infection

Switzerland
Amgen

Recruiting

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression (FORTITUDE-301)

Solid Tumors

Canada, Korea, Republic of, Australia, Netherlands, United States, Israel, Austria, Spain, United Kingdom, France, Belgium, Japan, Czechia, Hungary, Poland, Brazil, Italy, Argentina, Denmark, Greece, Mexico, Switzerland, Romania, Finland and more
University Hospital, Basel, Switzerland
Stiftung Forschung Infektionskrankheiten, Basel, Switzerland

Completed

Simplified GBS Screening and Prevalence of ESBL in Pregnant Women

Group B Streptococcal Infection | Infection Due to ESBL Bacteria

Switzerland
Ligue Pulmonaire Genevoise

Completed

Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant Recipients

Latent Tuberculosis Infection

Switzerland
Biofabri, S.L
Centre Hospitalier Universitaire Vaudois; TuBerculosis Vaccine Initiative; Universidad...

Completed

Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine. (MTBVAC)

Healthy | Tuberculosis

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection (TARGET III)

Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)

Switzerland
Sanofi

Completed

Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers

Pneumococcal Infections | Pneumococcal Pneumonia

Switzerland
Innovative Medicines for Tuberculosis
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple Dosing

Tuberculosis, Pulmonary

Switzerland
University Hospital Inselspital, Berne

Completed

Stress Response in Emergency Among Physicians in Helicopter and Ambulance Based Emergency Medical Systems

Hormone Disturbance | Stress Related Disorder | Stress Reaction

Switzerland
Innovative Medicines for Tuberculosis
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation

Tuberculosis | Tuberculosis, Pulmonary

Switzerland
University Hospital Inselspital, Berne
Swiss National Science Foundation

Completed

The Effects of Growth Hormone (GH) on Lipid Depots

Growth Hormone Deficiency

Switzerland
Andrej Trampuz
University of Lausanne Hospitals; Schulthess Klinik; Kantonsspital Liestal

Unknown

Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection (Dapto-Studie)

Staphylococcal Infections

Switzerland
Centre Hospitalier Universitaire Vaudois

Recruiting

Minipuberty in Infants Born With Potential Hypogonadism Hypogonadotrope (MiniNO)

DSD | CHH

Switzerland
Insel Gruppe AG, University Hospital Bern
Idiap Research Institute; CSEM Centre Suisse d'Electronique et de Microtechnique...

Completed

GLEAM: Noninvasive Glucose Measurement Using Impedance Tomography (GLEAM)

Diabetes Mellitus

Switzerland
OnkoZentrum Zürich AG
University of Zurich; Palleos Healthcare GmbH

Completed

HER2-directed Biosimilar in Breast Cancer: Real World ePRO (OGIPRO)

HER2-positive Breast Cancer | Biosimilar | Patient Reported Outcome

Switzerland
University of Applied Sciences of Western Switzerland
Swiss National Science Foundation; University of Lausanne Hospitals; Réseau d... and other collaborators

Completed

Impact of a Telenursing Service on Satisfaction and Health Outcomes of Children With Inflammatory Rheumatic Diseases

Inflammatory Rheumatism

Switzerland
University of Zurich

Unknown

The Swiss Glucose Variability Study

Type 2 Diabetes

Switzerland
University Hospital, Geneva

Completed

Interaction Between Anaesthetics and Methylene Blue

Hyperparathyroidism

Switzerland
Novartis Pharmaceuticals

Completed

Real-world Effectiveness of Asciminib and Treatment Patterns in Patients With Chronic Myeloid Leukemia With T315I Mutation - a Chart Review Study of Patients Treated in the Asciminib Managed Access Program (MAP)

Chronic Myeloid Leukemia With T315I Mutation

Switzerland
University of Zurich

Completed

Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.

Community-acquired Pneumonia

Switzerland
Juerg Hafner

Recruiting

Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream (LIDOTETRA)

Ulcer, Leg | Ulcus Cruris | Ulcer Venous | Ecthyma

Switzerland
Merck KGaA, Darmstadt, Germany

Terminated

AS900672-Enriched in Ovulation Induction

Ovulation Induction

Switzerland
University Hospital, Basel, Switzerland

Completed

Effects of Oral Pre-loads on Subsequent Energy Intake

Gastrointestinal Hormones | Energy Intake | Glycemic Control | Appetite | Satiation

Switzerland
Sanofi

Completed

Study of Two Investigational Pneumococcal Vaccines in Healthy Adults

Pneumococcal Infections | Streptococcus Pneumoniae Infections | Pneumococcal Pneumonia

Switzerland
MerLion Pharmaceuticals GmbH

Terminated

First Time in Man Trial for Friulimicin B

Staphylococcal Skin Infections | Community Acquired Pneumonia

Switzerland
University Hospital, Basel, Switzerland

Active, not recruiting

Effects of Oral Xylitol on Subsequent Energy Intake

Gastrointestinal Hormones | Energy Intake | Glycemic Control | Appetite | Satiation

Switzerland
University Hospital Inselspital, Berne

Completed

Systematic Evaluation of Continuous Glucose Monitoring Data (SECOND)

Diabetes Mellitus

Switzerland

Clinical Trials on Hormone Receptor Positive in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations